<DOC>
	<DOCNO>NCT00369694</DOCNO>
	<brief_summary>The purpose study determine whether 24 hour Terlipressin effective 72 hour Terlipressin prevent re-bleed esophageal variceal bleed control endoscopic therapy ( variceal band ligation sclerotherapy ) low moderate risk variceal bleed patient hence save cost may decrease length hospital stay especially I.C.U high dependency unit .</brief_summary>
	<brief_title>Short Course Terlipressin Control Acute Variceal Bleeding</brief_title>
	<detailed_description>The esophageal variceal bleed usually control endoscopic treatment variceal band ligation sclerotherapy along vasoactive drug like Terlipressin Octreotide . The risk re-bleeding high initial 5 day first presentation . Terlipressin usually give 3 day ( 72 hour ) . In study try prove among low moderate risk patient , short course 1 day ( 24 hour ) Terlipressin effective 3 day ( 72 hour ) prevent re-bleed bleeding control endoscopic therapy . This intervention save 2 day cost incur Terlipressin may also help decrease length hospital stay future .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<criteria>Acute esophageal variceal bleed Liver cirrhosis Child 's score &lt; /= 11 Patient Mechanical ventilator ionotropic support Active angina , Recent Myocardial infarction dynamic EKG change Failure control variceal bleed initial endoscopy Gastric variceal bleed Spontaneous bacterial peritonitis presentation Hepatocellular carcinoma liver metastatic malignancy Portal vein thrombosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Esophageal varix</keyword>
	<keyword>Portal Hypertension</keyword>
	<keyword>Melena</keyword>
	<keyword>Hematemesis</keyword>
	<keyword>Gastrointestinal Hemorrhage</keyword>
	<keyword>Terlipressin</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
</DOC>